Inventor · disambiguated record
Fergus Shanahan
Also filed as: SHANAHAN FERGUS
10 granted patents·31 pending applications·154 citations·filing 2001–2021
89Inventor score
Files withUNIV COLLEGE CORK NAT UNIV IE74D PHARMA PLC6ENTPR IE TRD AS BIORESEARCH IE4ALIMENTARY HEALTH LTD3UNIV COLLEGE CORK NATIONAL UNIV OF IRELAND CORK3
Top patents by PatentIndex Score
41 records- 0196US10086021B2Compositions comprising bacterial strains4D PHARMA PLC·Filed 2018·Granted Oct 2, 2018·42 cites·17 claims
- 0296US7195906B2Bifidobacterium in the treatment of inflammatory diseaseUNIV COLLEGE CORK NAT UNIV IE·Filed 2004·Granted Mar 27, 2007·88 cites·33 claims
- 0394US10485830B2Compositions comprising bacterial strains4D PHARMA PLC·Filed 2018·Granted Nov 26, 2019·2 cites·17 claims
- 0488US10543238B2Compositions comprising bacterial strains4D PHARMA PLC·Filed 2018·Granted Jan 28, 2020·2 cites·15 claims
- 0588US7390519B2Probiotic Lactobacillus salivarius strainsALIMENTARY HEALTH LTD·Filed 2005·Granted Jun 24, 2008·13 cites·20 claims
- 0682US10898526B2Compositions comprising bacterial strains4D PHARMA PLC·Filed 2019·Granted Jan 26, 2021·2 cites·14 claims
- 0774US2022128556A1Methods of diagnosing disease4D PHARMA CORK LTD·Filed 2021·Application pending·0 cites
- 0874US2022165361A1Methods of diagnosing disease4D PHARMA CORK LTD·Filed 2021·Application pending·0 cites
- 0970US9808493B2Exopolysaccharide-producing bacteria, and uses thereof for protecting heart healthUNIV COLLEGE CORK—NATIONAL UNIV OF IRELAND CORK·Filed 2013·Granted Nov 7, 2017·1 cites·6 claims
- 1070US8216563B2Methods of determining efficacy of treatments of diseases of the bowelCHEN KER-SANG·Filed 2011·Granted Jul 10, 2012·2 cites·19 claims
- 1170US2021196765A1Compositions comprising bacterial strains4D PHARMA PLC·Filed 2020·Application pending·0 cites
- 1270US2010112003A1Bifidobacterium in the treatment of inflammatory diseaseUNIV COLLEGE CORK NAT UNIV IE·Filed 2009·Application pending·0 cites
- 1368US2021163878A1Modulation of tissue fatty acid composition of a host by human gut bacteriaPREC GROUP LIMITED·Filed 2020·Application pending·0 cites
- 1467US2008311080A1Bifidobacterium in the treatment of inflammatory diseaseENTPR IE TRD AS BIORESEARCH IE·Filed 2008·Application pending·0 cites
- 1564US2008057109A1Bifidobacterium in the treatment of inflammatory diseaseUNIV COLLEGE CORK NAT UNIV IE·Filed 2007·Application pending·0 cites
- 1662US2010284979A1Modulation of Tissue Fatty Acid Composition of a Host by Human Gut BacteriaUNIV COLLEGE CORK NAT UNIV IE·Filed 2008·Application pending·0 cites
- 1762US2007141039A1Bifidobacterium in the treatment of inflammatory diseaseENTPR IE TRD AS BIORESEARCH IE·Filed 2006·Application pending·0 cites
- 1861US2005214272A1Bifidobacterium in the treatment of inflammatory diseaseUNIV COLLEGE CORK NAT UNIV IE·Filed 2004·Application pending·0 cites
- 1961US2006292133A1Use of lactobacillus salivariusUNIV COLLEGE CORK NAT UNIV IE·Filed 2005·Application pending·0 cites
- 2061US2006002908A1Bifidobacterium in the treatment of inflammatory diseaseNAT UNIVERSITY·Filed 2004·Application pending·0 cites
- 2159US2005084482A1Use of lactobacillus salivariusUNIV COLLEGE CORK NAT UNIV IE·Filed 2004·Application pending·0 cites
- 2258US7923000B2Methods of determining efficacy of treatments of inflammatory diseases of the bowelPROCTER & GAMBLE·Filed 2004·Granted Apr 12, 2011·2 cites·21 claims
- 2357US2019264168A1Modulation of tissue fatty acid composition of a host by human gut bacteriaUNIV COLLEGE CORK NATIONAL UNIV OF IRELAND·Filed 2018·Application pending·0 cites
- 2457US2003215467A1Bifidobacteriumin the treatment of inflammatory diseaseENTPR IE TRD AS BIORESEARCH IE·Filed 2003·Application pending·0 cites
- 2557US2003170217A1Bifidobacterium in the treatment of inflammatory diseaseENTPR IE TRD AS BIORESEARCH IE·Filed 2003·Application pending·0 cites
- 2655US2013209429A1Modulation of Tissue Fatty Acid Composition of a Host by Human Gut BacteriaIRELAND CORK UNIVERSITY COLLEGE CORK NAT UNIVERSITY OF·Filed 2013·Application pending·0 cites
- 2754US2003166257A1Use of Lactobacillus salivariusENTPR IRELAND·Filed 2002·Application pending·0 cites
- 2853US2002006432A1Bifidobacterium in the treatment of inflammatory diseaseFiled 2001·Application pending·0 cites
- 2953US2017313974A1Modulation of Tissue Fatty Acid Composition of a Host by Human Gut BacteriaUNIV COLLEGE CORK NAT UNIV OF IRELAND·Filed 2016·Application pending·0 cites
- 3050US2013217600A1Methods of determining efficacy of treatments of diseases of the bowelCHEN KER-SANG·Filed 2012·Application pending·0 cites
- 3149US2004265279A1Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activityFiled 2004·Application pending·0 cites
- 3249US2021327580A1Method for Stratifying IBS Patients4D PHARMA PLC·Filed 2020·Application pending·0 cites
- 3348US2006121015A1Probiotic bifidobacterium strainsALIMENTARY HEALTH LTD·Filed 2005·Application pending·0 cites
- 3448US2006204485A1Probiotics in the treatment of atypical depression and other disorders characterised by hypothalamic pitiuitary-ardrenal axis over activityALIMENTARY HEALTH LTD·Filed 2006·Application pending·0 cites
- 3547US2003092163A1Probiotic bifidobacterium strainsFiled 2002·Application pending·0 cites
- 3647US2003091549A1Probiotic lactobacillus salivarius strainsFiled 2002·Application pending·0 cites
- 3745US11061029B2Methods of determining colorectal cancer status in an individualUNIV COLLEGE CORK—NATIONAL UNIV OF IRELAND CORK·Filed 2019·Granted Jul 13, 2021·0 cites·10 claims
- 3845US2006088514A1Formulation comprising a bacterial strainO'MAHONY LIAM·Filed 2005·Application pending·0 cites
- 3944US2002081311A1Probiatic productFiled 2001·Application pending·0 cites
- 4041US2003113306A1Probiotic lactobacillus casei strainsFiled 2002·Application pending·0 cites
- 4136US2020317738A1Methods for increasing proliferation of mammalian cellsUNIV COLLEGE CORK NATIONAL UNIV OF IRELAND CORK·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fergus Shanahan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →